• News
  • SAN DIEGO
  • Health

Scripps, partners win $300K for cervical cancer diagnostic tool

The Vodafone America Foundation awarded $300,000 for the collaborative development and testing of a smartphone-based cervical cancer diagnostic tool by Mobile OCT, Scripps Health, the International Community Foundation (ICF) and Fronteras Unidas Pro Salud.

Scripps Clinic gynecologist Bruce Kahn, M.D. will lead testing efforts through Scripps in San Diego and Fronteras Unidas Pro Salud in Tijuana. The International Community Foundation will serve as the project’s fiscal sponsor and provide additional technical expertise given the foundation’s previous involvement in a multi-year mobile health clinical study in Tijuana.

“We are deeply privileged to be recognized by Vodafone Americas’ Wireless Innovation Project, and will use this first place prize to bring our low-cost cancer screening technology to the women who need it most,” said Ariel Beery, CEO of MobileOCT. “Thanks to the support of Vodafone, our team is positioned to demonstrate the potential of using mobile health solutions to offer cost effective, life-saving diagnostics to the billions of women around the world without access to good reproductive health services.”

“Through efforts like this one, Scripps is playing a leading role in translating the latest medical technologies into high-quality, cost-effective diagnostic tools and treatments,” Kahn said. “I am privileged to be a part of this outstanding partnership.”

Leave Your Comment

Comments are moderated by SDDT, in accordance with the SDDT Comment Policy, and may not appear on this commentary until they have been reviewed and deemed appropriate for posting. Also, due to the volume of comments we receive, not all comments will be posted.

SDDT Comment Policy: SDDT encourages you to add a comment to this discussion. You may not post any unlawful, threatening, defamatory, obscene, pornographic or other material that would violate the law. All comments should be relevant to the topic and remain respectful of other authors and commenters. You are solely responsible for your own comments, the consequences of posting those comments, and the consequences of any reliance by you on the comments of others. By submitting your comment, you hereby give SDDT the right, but not the obligation, to post, air, edit, exhibit, telecast, cablecast, webcast, re-use, publish, reproduce, use, license, print, distribute or otherwise use your comment(s) and accompanying personal identifying and other information you provide via all forms of media now known or hereafter devised, worldwide, in perpetuity. SDDT Privacy Statement.

User Response
0 UserComments

Leave Your Comment

Comments are moderated by SDDT, in accordance with the SDDT Comment Policy, and may not appear on this commentary until they have been reviewed and deemed appropriate for posting. Also, due to the volume of comments we receive, not all comments will be posted.

SDDT Comment Policy: SDDT encourages you to add a comment to this discussion. You may not post any unlawful, threatening, defamatory, obscene, pornographic or other material that would violate the law. All comments should be relevant to the topic and remain respectful of other authors and commenters. You are solely responsible for your own comments, the consequences of posting those comments, and the consequences of any reliance by you on the comments of others. By submitting your comment, you hereby give SDDT the right, but not the obligation, to post, air, edit, exhibit, telecast, cablecast, webcast, re-use, publish, reproduce, use, license, print, distribute or otherwise use your comment(s) and accompanying personal identifying and other information you provide via all forms of media now known or hereafter devised, worldwide, in perpetuity. SDDT Privacy Statement.